SBPYX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SBPYX Analyst Rating

Moderate Buy

65 Buy

17 Hold

0 Sell

Based on the consensus analyst ratings on 82 stocks held in SBPYX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SBPYX Analyst Price Target

Average Price Target

$43.38

Based on 82 Wall Street analysts offering 12 month price targets to ClearBridge Small Cap Growth Fd Cl I holdings in the last 3 months. The average price target is $43.38 with a high forecast of $51.38 and a low forecast of $34.42. The average price target represents a 20.11% change from the last price of $36.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"33":"$33","52":"$52","37.75":"$37.8","42.5":"$42.5","47.25":"$47.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":51.382,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$51.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":43.382,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$43.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.416,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$34.42</span>\n  </div></div>","useHTML":true}}],"tickPositions":[33,37.75,42.5,47.25,52],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.68,38.734,39.788,40.842,41.896,42.95,44.004,45.058,46.111999999999995,47.166,48.22,49.274,50.327999999999996,{"y":51.382,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.68,38.11861538461538,38.55723076923077,38.99584615384615,39.43446153846154,39.87307692307692,40.311692307692304,40.75030769230769,41.188923076923075,41.62753846153846,42.066153846153846,42.50476923076923,42.943384615384616,{"y":43.382,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.68,37.42892307692308,37.177846153846154,36.92676923076923,36.67569230769231,36.424615384615386,36.17353846153846,35.92246153846153,35.67138461538461,35.42030769230769,35.169230769230765,34.91815384615384,34.66707692307692,{"y":34.416,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.92,"date":1717372800000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.02,"date":1719792000000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.06,"date":1722470400000,"info":"<div>Price: <b>$37<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.47,"date":1725321600000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.78,"date":1727740800000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.02,"date":1730419200000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":42.4,"date":1733097600000,"info":"<div>Price: <b>$42<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.83,"date":1735776000000,"info":"<div>Price: <b>$39<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":41.4,"date":1738540800000,"info":"<div>Price: <b>$41<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.9,"date":1740960000000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.79,"date":1743465600000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.57,"date":1746057600000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.68,"date":1748822400000,"info":"<div>Price: <b>$38<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$51.38

Average Price Target$43.38

Lowest Price Target$34.42

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SBPYX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BHVN

Biohaven Ltd.

8 Buy

1 Hold

0 Sell

Strong Buy

$53.33

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PCVX

Vaxcyte, Inc.

11 Buy

0 Hold

0 Sell

Strong Buy

$117.88

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VKTX

Viking Therapeutics

13 Buy

1 Hold

0 Sell

Strong Buy

$90.69

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RARE

Ultragenyx Pharmaceutical, Inc.

14 Buy

1 Hold

0 Sell

Strong Buy

$87.87

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ZETA

Zeta Global Holdings Corp. Class A

11 Buy

2 Hold

0 Sell

Strong Buy

$27.00

SBPYX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALGM

Allegro Microsystems, Inc.

8 Buy

1 Hold

0 Sell

Strong Buy

$26.33

xxxxxxxxxxxxxxxxxxxxxxxxxxx

WING

Wingstop Inc.

17 Buy

5 Hold

0 Sell

Strong Buy

$338.81

xxxxxxxxxxxxxxxxxxxxxxxxxxx

QLYS

Qualys Inc

3 Buy

9 Hold

3 Sell

Hold

$131.33

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CASY

Casey's General Stores

6 Buy

3 Hold

1 Sell

Moderate Buy

$462.89

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FLR

Fluor Corporation

5 Buy

3 Hold

0 Sell

Moderate Buy

$42.50

SBPYX Mutual Fund FAQ

What is SBPYX’s average 12-month price target, according to analysts?

Based on analyst ratings, ClearBridge Small Cap Growth Fd Cl I’s 12-month average price target is 43.38.

What is SBPYX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for SBPYX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SBPYX a Buy, Sell or Hold?

ClearBridge Small Cap Growth Fd Cl I has a consensus rating of Moderate Buy which is based on 65 buy ratings, 17 hold ratings and 0 sell ratings.

What is ClearBridge Small Cap Growth Fd Cl I’s price target?

The average price target for ClearBridge Small Cap Growth Fd Cl I is 43.38. This is based on 82 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $51.38 ,the lowest forecast is $34.42. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about ClearBridge Small Cap Growth Fd Cl I?

ClearBridge Small Cap Growth Fd Cl I’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 82 Wall Streets Analysts.

How can I buy shares of SBPYX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing